10 20 30 40 50 60 70 80 5M4U - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSFERASE 19-OCT-16 5M4U
TITLE ORTHORHOMBIC COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC TITLE 2 SUBUNIT (ISOFORM CK2ALPHA') WITH THE INHIBITOR 4'-CARBOXY-6,8-CHLORO- TITLE 3 FLAVONOL (FLC21)
COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA'; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CK II ALPHA'; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A2, CK2A2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS PROTEIN KINASE CK2, CASEIN KINASE 2, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR K.NIEFIND,N.BISCHOFF,S.M.YARMOLUK,V.G.BDZHOLA,A.G.GOLUB,A.O.BALANDA, AUTHOR 2 A.O.PRYKHOD'KO
REVDAT 4 17-MAY-17 5M4U 1 JRNL REVDAT 3 10-MAY-17 5M4U 1 JRNL REVDAT 2 25-JAN-17 5M4U 1 JRNL REVDAT 1 18-JAN-17 5M4U 0
JRNL AUTH K.NIEFIND,N.BISCHOFF,A.G.GOLUB,V.G.BDZHOLA,A.O.BALANDA, JRNL AUTH 2 A.O.PRYKHOD'KO,S.M.YARMOLUK JRNL TITL STRUCTURAL HYPERVARIABILITY OF THE TWO HUMAN PROTEIN KINASE JRNL TITL 2 CK2 CATALYTIC SUBUNIT PARALOGS REVEALED BY COMPLEX JRNL TITL 3 STRUCTURES WITH A FLAVONOL- AND A JRNL TITL 4 THIENO[2,3-D]PYRIMIDINE-BASED INHIBITOR. JRNL REF PHARMACEUTICALS V. 10 2017 JRNL REFN ESSN 1424-8247 JRNL PMID 28085026 JRNL DOI 10.3390/PH10010009
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.GUERRA,N.BISCHOFF,V.G.BDZHOLA,S.M.YARMOLUK,O.G.ISSINGER, REMARK 1 AUTH 2 A.G.GOLUB,K.NIEFIND REMARK 1 TITL A NOTE OF CAUTION ON THE ROLE OF HALOGEN BONDS FOR PROTEIN REMARK 1 TITL 2 KINASE/INHIBITOR RECOGNITION SUGGESTED BY HIGH- AND LOW-SALT REMARK 1 TITL 3 CK2ALPHA COMPLEX STRUCTURES. REMARK 1 REF ACS CHEM. BIOL. V. 10 1654 2015 REMARK 1 REFN ESSN 1554-8937 REMARK 1 PMID 25961323 REMARK 1 DOI 10.1021/ACSCHEMBIO.5B00235 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.G.GOLUB,V.G.BDZHOLA,N.V.BRIUKHOVETSKA,A.O.BALANDA, REMARK 1 AUTH 2 O.P.KUKHARENKO,I.M.KOTEY,O.V.OSTRYNSKA,S.M.YARMOLUK REMARK 1 TITL SYNTHESIS AND BIOLOGICAL EVALUATION OF SUBSTITUTED REMARK 1 TITL 2 (THIENO[2,3-D]PYRIMIDIN-4-YLTHIO)CARBOXYLIC ACIDS AS REMARK 1 TITL 3 INHIBITORS OF HUMAN PROTEIN KINASE CK2. REMARK 1 REF EUR J MED CHEM V. 46 870 2011 REMARK 1 REFN ISSN 1768-3254 REMARK 1 PMID 21276643 REMARK 1 DOI 10.1016/J.EJMECH.2010.12.025 REMARK 1 REFERENCE 3 REMARK 1 AUTH A.G.GOLUB,V.G.BDZHOLA,Y.V.KYSHENIA,V.M.SAPELKIN, REMARK 1 AUTH 2 A.O.PRYKHOD'KO,O.P.KUKHARENKO,O.V.OSTRYNSKA,S.M.YARMOLUK REMARK 1 TITL STRUCTURE-BASED DISCOVERY OF NOVEL FLAVONOL INHIBITORS OF REMARK 1 TITL 2 HUMAN PROTEIN KINASE CK2. REMARK 1 REF MOL. CELL. BIOCHEM. V. 356 107 2011 REMARK 1 REFN ISSN 1573-4919 REMARK 1 PMID 21735097 REMARK 1 DOI 10.1007/S11010-011-0945-8
REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.50 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 28094 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.910 REMARK 3 FREE R VALUE TEST SET COUNT : 1142 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.5107 - 4.3893 1.00 3749 145 0.1692 0.1974 REMARK 3 2 4.3893 - 3.4844 1.00 3554 162 0.1362 0.1703 REMARK 3 3 3.4844 - 3.0440 1.00 3556 136 0.1530 0.1952 REMARK 3 4 3.0440 - 2.7658 1.00 3486 150 0.1732 0.2402 REMARK 3 5 2.7658 - 2.5675 1.00 3511 133 0.1802 0.2671 REMARK 3 6 2.5675 - 2.4162 1.00 3480 138 0.1785 0.2356 REMARK 3 7 2.4162 - 2.2952 1.00 3502 138 0.2043 0.2406 REMARK 3 8 2.2952 - 2.1953 0.94 3256 140 0.2639 0.2900 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.030 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.44 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2925 REMARK 3 ANGLE : 0.576 3943 REMARK 3 CHIRALITY : 0.043 402 REMARK 3 PLANARITY : 0.003 502 REMARK 3 DIHEDRAL : 15.776 1739 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 3 THROUGH 130 ) REMARK 3 ORIGIN FOR THE GROUP (A): 3.0720 -14.8249 -11.4226 REMARK 3 T TENSOR REMARK 3 T11: 0.1769 T22: 0.2237 REMARK 3 T33: 0.1653 T12: 0.0033 REMARK 3 T13: 0.0064 T23: 0.0158 REMARK 3 L TENSOR REMARK 3 L11: 1.1914 L22: 0.6533 REMARK 3 L33: 0.9669 L12: -0.2131 REMARK 3 L13: -0.2470 L23: 0.4476 REMARK 3 S TENSOR REMARK 3 S11: -0.0460 S12: -0.2706 S13: -0.0314 REMARK 3 S21: 0.1674 S22: 0.0302 S23: -0.0167 REMARK 3 S31: 0.0537 S32: 0.1107 S33: 0.0005 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 131 THROUGH 334 ) REMARK 3 ORIGIN FOR THE GROUP (A): 14.9445 -13.2497 -30.2894 REMARK 3 T TENSOR REMARK 3 T11: 0.1125 T22: 0.0986 REMARK 3 T33: 0.1013 T12: -0.0043 REMARK 3 T13: -0.0033 T23: 0.0057 REMARK 3 L TENSOR REMARK 3 L11: 1.3036 L22: 0.8480 REMARK 3 L33: 0.7755 L12: 0.1466 REMARK 3 L13: -0.0397 L23: 0.1086 REMARK 3 S TENSOR REMARK 3 S11: -0.0262 S12: 0.0663 S13: 0.0046 REMARK 3 S21: -0.0384 S22: 0.0365 S23: -0.0445 REMARK 3 S31: 0.0006 S32: -0.0207 S33: -0.0037 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 5M4U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1200001933.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29246 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.195 REMARK 200 RESOLUTION RANGE LOW (A) : 44.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.19090 REMARK 200 R SYM (I) : 0.19090 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.9900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 1.18500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.720 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 3OFM REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN STOCK SOLUTION: 5.5 MG/ML REMARK 280 CK2ALPHA'D39G-C336S IN 0.5 M NACL, 25 MM TRIS/HCL, PH 8.5; REMARK 280 INHIBITOR STOCK SOLUTION: 10 MM INHIBITOR IN DMSO; PROTEIN/ REMARK 280 INHIBITOR COMPLEX SOLUTION: 90 MICROLITER PROTEIN STOCK SOLUTION REMARK 280 + 10 MICROLITER INHIBITOR STOCK SOLUTION; RESERVOIR SOLUTION: 25 REMARK 280 % PEG5000 MME, 0.2 M AMMONIUM SULPHATE, 0.1 M MES BUFFER, PH 6.5; REMARK 280 DROP SOLUTION BEFORE EQULIBRATION: 0.3 MICROLITER PROTEIN/ REMARK 280 INHIBITOR COMPLEX SOLUTION + 0.3 MICROLITER RESERVOIR SOLUTION, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.42500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.17200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.89000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 71.17200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.42500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.89000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 SER A -3 REMARK 465 GLN A -2 REMARK 465 ASP A -1 REMARK 465 PRO A 0 REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 PRO A 335 REMARK 465 SER A 336 REMARK 465 ALA A 337 REMARK 465 ASP A 338 REMARK 465 ASN A 339 REMARK 465 ALA A 340 REMARK 465 VAL A 341 REMARK 465 LEU A 342 REMARK 465 SER A 343 REMARK 465 SER A 344 REMARK 465 GLY A 345 REMARK 465 LEU A 346 REMARK 465 THR A 347 REMARK 465 ALA A 348 REMARK 465 ALA A 349 REMARK 465 ARG A 350
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 48 34.87 -141.89 REMARK 500 PRO A 73 95.05 -53.82 REMARK 500 ASP A 157 39.60 -153.96 REMARK 500 ASP A 176 80.45 56.43 REMARK 500 ALA A 194 -177.94 58.81 REMARK 500 MET A 209 53.28 -91.14 REMARK 500 ASP A 211 -157.50 -150.63 REMARK 500 HIS A 235 74.90 -105.33 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 813 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH A 814 DISTANCE = 7.63 ANGSTROMS REMARK 525 HOH A 815 DISTANCE = 8.80 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7FC A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 408 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 409 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 410 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 411
DBREF 5M4U A 1 350 UNP P19784 CSK22_HUMAN 1 350
SEQADV 5M4U HIS A -9 UNP P19784 EXPRESSION TAG SEQADV 5M4U HIS A -8 UNP P19784 EXPRESSION TAG SEQADV 5M4U HIS A -7 UNP P19784 EXPRESSION TAG SEQADV 5M4U HIS A -6 UNP P19784 EXPRESSION TAG SEQADV 5M4U HIS A -5 UNP P19784 EXPRESSION TAG SEQADV 5M4U HIS A -4 UNP P19784 EXPRESSION TAG SEQADV 5M4U SER A -3 UNP P19784 EXPRESSION TAG SEQADV 5M4U GLN A -2 UNP P19784 EXPRESSION TAG SEQADV 5M4U ASP A -1 UNP P19784 EXPRESSION TAG SEQADV 5M4U PRO A 0 UNP P19784 EXPRESSION TAG SEQADV 5M4U GLY A 39 UNP P19784 ASP 39 ENGINEERED MUTATION SEQADV 5M4U SER A 336 UNP P19784 CYS 336 ENGINEERED MUTATION
SEQRES 1 A 360 HIS HIS HIS HIS HIS HIS SER GLN ASP PRO MET PRO GLY SEQRES 2 A 360 PRO ALA ALA GLY SER ARG ALA ARG VAL TYR ALA GLU VAL SEQRES 3 A 360 ASN SER LEU ARG SER ARG GLU TYR TRP ASP TYR GLU ALA SEQRES 4 A 360 HIS VAL PRO SER TRP GLY ASN GLN ASP GLY TYR GLN LEU SEQRES 5 A 360 VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU VAL PHE SEQRES 6 A 360 GLU ALA ILE ASN ILE THR ASN ASN GLU ARG VAL VAL VAL SEQRES 7 A 360 LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE LYS ARG SEQRES 8 A 360 GLU VAL LYS ILE LEU GLU ASN LEU ARG GLY GLY THR ASN SEQRES 9 A 360 ILE ILE LYS LEU ILE ASP THR VAL LYS ASP PRO VAL SER SEQRES 10 A 360 LYS THR PRO ALA LEU VAL PHE GLU TYR ILE ASN ASN THR SEQRES 11 A 360 ASP PHE LYS GLN LEU TYR GLN ILE LEU THR ASP PHE ASP SEQRES 12 A 360 ILE ARG PHE TYR MET TYR GLU LEU LEU LYS ALA LEU ASP SEQRES 13 A 360 TYR CYS HIS SER LYS GLY ILE MET HIS ARG ASP VAL LYS SEQRES 14 A 360 PRO HIS ASN VAL MET ILE ASP HIS GLN GLN LYS LYS LEU SEQRES 15 A 360 ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR HIS PRO SEQRES 16 A 360 ALA GLN GLU TYR ASN VAL ARG VAL ALA SER ARG TYR PHE SEQRES 17 A 360 LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET TYR ASP SEQRES 18 A 360 TYR SER LEU ASP MET TRP SER LEU GLY CYS MET LEU ALA SEQRES 19 A 360 SER MET ILE PHE ARG ARG GLU PRO PHE PHE HIS GLY GLN SEQRES 20 A 360 ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS VAL LEU SEQRES 21 A 360 GLY THR GLU GLU LEU TYR GLY TYR LEU LYS LYS TYR HIS SEQRES 22 A 360 ILE ASP LEU ASP PRO HIS PHE ASN ASP ILE LEU GLY GLN SEQRES 23 A 360 HIS SER ARG LYS ARG TRP GLU ASN PHE ILE HIS SER GLU SEQRES 24 A 360 ASN ARG HIS LEU VAL SER PRO GLU ALA LEU ASP LEU LEU SEQRES 25 A 360 ASP LYS LEU LEU ARG TYR ASP HIS GLN GLN ARG LEU THR SEQRES 26 A 360 ALA LYS GLU ALA MET GLU HIS PRO TYR PHE TYR PRO VAL SEQRES 27 A 360 VAL LYS GLU GLN SER GLN PRO SER ALA ASP ASN ALA VAL SEQRES 28 A 360 LEU SER SER GLY LEU THR ALA ALA ARG
HET 7FC A 401 23 HET GOL A 402 6 HET GOL A 403 6 HET GOL A 404 6 HET GOL A 405 6 HET GOL A 406 6 HET ACT A 407 4 HET ACT A 408 4 HET ACT A 409 4 HET CL A 410 1 HET SO4 A 411 5
HETNAM 7FC 4-[6,8-BIS(CHLORANYL)-3-OXIDANYL-4-OXIDANYLIDENE- HETNAM 2 7FC CHROMEN-2-YL]BENZOIC ACID HETNAM GOL GLYCEROL HETNAM ACT ACETATE ION HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 2 7FC C16 H8 CL2 O5 FORMUL 3 GOL 5(C3 H8 O3) FORMUL 8 ACT 3(C2 H3 O2 1-) FORMUL 11 CL CL 1- FORMUL 12 SO4 O4 S 2- FORMUL 13 HOH *315(H2 O)
HELIX 1 AA1 SER A 21 ASP A 26 1 6 HELIX 2 AA2 TYR A 27 HIS A 30 5 4 HELIX 3 AA3 LYS A 75 ARG A 90 1 16 HELIX 4 AA4 ASP A 121 GLN A 127 1 7 HELIX 5 AA5 THR A 130 LYS A 151 1 22 HELIX 6 AA6 LYS A 159 HIS A 161 5 3 HELIX 7 AA7 SER A 195 LYS A 199 5 5 HELIX 8 AA8 GLY A 200 VAL A 205 1 6 HELIX 9 AA9 TYR A 212 ARG A 229 1 18 HELIX 10 AB1 ASP A 238 GLY A 251 1 14 HELIX 11 AB2 GLY A 251 TYR A 262 1 12 HELIX 12 AB3 ASP A 267 ILE A 273 5 7 HELIX 13 AB4 ARG A 281 ILE A 286 5 6 HELIX 14 AB5 ASN A 290 VAL A 294 5 5 HELIX 15 AB6 SER A 295 LEU A 306 1 12 HELIX 16 AB7 THR A 315 GLU A 321 1 7 HELIX 17 AB8 HIS A 322 VAL A 329 5 8
SHEET 1 AA1 6 GLY A 35 ASN A 36 0 SHEET 2 AA1 6 LEU A 98 LYS A 103 1 O THR A 101 N GLY A 35 SHEET 3 AA1 6 PRO A 110 GLU A 115 -1 O VAL A 113 N ILE A 99 SHEET 4 AA1 6 ARG A 65 ILE A 70 -1 N VAL A 67 O PHE A 114 SHEET 5 AA1 6 GLU A 53 ASN A 59 -1 N PHE A 55 O VAL A 68 SHEET 6 AA1 6 TYR A 40 LEU A 46 -1 N VAL A 43 O GLU A 56 SHEET 1 AA2 2 ILE A 153 MET A 154 0 SHEET 2 AA2 2 GLU A 181 PHE A 182 -1 O GLU A 181 N MET A 154 SHEET 1 AA3 2 VAL A 163 ASP A 166 0 SHEET 2 AA3 2 LYS A 171 LEU A 174 -1 O LYS A 171 N ASP A 166
CISPEP 1 GLU A 231 PRO A 232 0 -8.58
SITE 1 AC1 13 ARG A 48 VAL A 67 LYS A 69 ILE A 96 SITE 2 AC1 13 PHE A 114 GLU A 115 TYR A 116 ILE A 117 SITE 3 AC1 13 MET A 164 ILE A 175 ASP A 176 HOH A 542 SITE 4 AC1 13 HOH A 646 SITE 1 AC2 4 TRP A 34 LYS A 80 LYS A 103 HOH A 717 SITE 1 AC3 4 ARG A 9 ALA A 10 ALA A 14 HOH A 501 SITE 1 AC4 5 TRP A 25 HIS A 184 GLN A 187 ACT A 408 SITE 2 AC4 5 HOH A 527 SITE 1 AC5 6 HIS A 277 SER A 278 LYS A 280 HOH A 505 SITE 2 AC5 6 HOH A 536 HOH A 553 SITE 1 AC6 7 PHE A 122 LYS A 123 HIS A 161 GLU A 231 SITE 2 AC6 7 HOH A 651 HOH A 672 HOH A 682 SITE 1 AC7 4 GLU A 15 SER A 18 LEU A 19 ASN A 284 SITE 1 AC8 4 ASP A 26 TYR A 27 GLU A 28 GOL A 404 SITE 1 AC9 2 ARG A 192 LYS A 199 SITE 1 AD1 2 GLU A 87 ARG A 90 SITE 1 AD2 6 ARG A 81 ARG A 156 ASN A 190 HOH A 552 SITE 2 AD2 6 HOH A 628 HOH A 657
CRYST1 46.850 83.780 142.344 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.021345 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011936 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007025 0.00000